Patents expiring in 2026

US 7098364

Phenylethanolamine compounds as β2-receptor agonists, and methods of use and preparation thereof

Jinzhou Jiutai Pharmaceutical Co., Ltd., China · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7098216

Thiazolopyrimidines useful as TNFα inhibitors

The Regents of the University of California · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7097965

Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7101863

Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative

BIODEX · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7101547

Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7101548

Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7101846

Methods and compositions for optimization of oxygen transport by cell-free systems

The Regents of the University of California · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7101557

Combined tissue factor methods for coagulation and tumor treatment

The Board of Regents of the University of Texas System · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7101932

Method for the preparation of 1-benzotriazolyl carbonate esters of poly (ethylene glycol)

Nektar Therapeutics AL, Corporation · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7101909

Calcium channel drugs and uses

Theravance, Inc. · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7102059

DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses

The Board of Regents University Community College System of Nevada on Behalf of the University of Nevada-Las Vegas · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7101867

Benzofuran derivatives, their production and use

Takeda Pharmaceutical Company Limited · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7101964

Intermediate for preparing glycopeptide derivatives

Theravance, Inc. · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7101899

5-pyridyl-1,3-azole compounds, process for producing the same and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7101541

Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7101852

Composition and method for treatment and prevention of restenosis

The Board of Regents of the University of Texas System · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105496

Methods and compositions for inhibiting angiogenesis

Northwestern University · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105695

Synthesis of combretastatin A-2 prodrugs

ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105643

Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the same, and crack cocaine conjugates

The United States of America as represented by the Attorney General of the Dept. of Justice · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105641

MCP-1 receptor antibodies

The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105546

Acyclic and cyclic amine derivatives

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105183

Chlorite in the treatment of neurodegenerative disease

The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105156

Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells

The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105572

Stable emulsion compositions

Takeda Pharmaceutical Company Limited · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105558

Gastrin and cholecystokinin receptor lignads (iv)

The James Black Foundation Limited · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105561

Use of etodolac for the treatment of prostate cancer

The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105560

Use of etodolac in the treatment of multiple myeloma

The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105514

Substituted indolealkanoic acids

The Institute for Dibetes Discovery LLC · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105488

G protein-coupled receptor antagonists

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105171

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105170

Latent human tuberculosis model, diagnostic antigens, and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105330

Human plasma hyaluronidase

The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105169

Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7109303

Modified cytokines for use in cancer therapy

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7109210

Quinuclidine derivatives and medicinal compositions containing the same

Almirall Prodesfarma S.A. · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7109172

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7109323

Formulation of boronic acid compounds

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7109179

Methods and compositions comprising DNA damaging agents and p53

The Board of Regents of the University of Texas System · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7109215

Compounds possessing neuronal activity

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7109200

Carbamate derivatives, process for producing the same and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7109188

Methods and compositions for treating atheroma, tumors and other neoplastic tissue

The Board of Regents of the University of Texas System · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7109245

Vasoconstrictor cannabinoid analogs

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7108975

Atlastin

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7108986

Glypican-1 in human breast cancer

The Regents of the University of California · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7109011

Hyaluronan synthase gene and uses thereof

The Board of Regents of the University of Oklahoma · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7108981

Specific binding agents for KSHV vIL-6 that neutralize a biological activity

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7109380

Cyclopentenedione antifungal compounds and methods for their use

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7112317

Combined methods and compositions for tumor vasculature targeting and tumor treatment

The Board of Regents of the University of Texas System · Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)